Form 4 for MUSA Murphy USA Inc.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001573516-26-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | MUSA | Click Christopher A | EVP, Strategy, Growth, Innova | M - OptEx | $0.00 | +1,843 | 6,558 | +39% | $0 |
| D | 2026-02-13 | 2026-02-11 | MUSA | Click Christopher A | EVP, Strategy, Growth, Innova | F - Tax | $363.36 | -798 | 5,760 | -12% | -$290.0K |
| DM | 2026-02-13 | 2026-02-11 | MUSA | Click Christopher A | EVP, Strategy, Growth, Innova | A - Grant | $0.00 | +6,163 | 4,099 | New | $0 |
| D | 2026-02-13 | 2026-02-11 | MUSA | Click Christopher A | EVP, Strategy, Growth, Innova | M - OptEx | $0.00 | -1,100 | 3,278 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-11 | M | A | 1,843 | $0.00 | 6,558 | D | — | — | (F1) Represents performance-based restricted Stock units that have vested and settled in shares of the Company's stock. Pursuant to the terms of the performance-based grant, the total includes 165.3% of the original award plus shares equivalent in value to accumulated dividends. |
| 2 | Common | Common Stock | 2026-02-11 | F | D | 798 | $363.36 | 5,760 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-11 | A | A | 589 | $0.00 | 1,646.83 | D | — · — to — | 589 Common Stock | (F3) Award granted under the 2023 Omnibus Incentive Plan. (F6) Includes dividend equivalent units accrued with respect to the underlying RSUs. (F5) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |
| 4 | Derivative | Performance Stock Unit | 2026-02-11 | M | D | 1,100 | $0.00 | 3,278 | D | — · — to — | 1,100 Common Stock | (F7) Award granted under the 2013 Long-Term Incentive Plan. (F5) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |
| 5 | Derivative | Performance Stock Unit | 2026-02-11 | A | A | 1,178 | $0.00 | 4,378 | D | — · — to — | 1,178 Common Stock | (F3) Award granted under the 2023 Omnibus Incentive Plan. (F5) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |
| 6 | Derivative | Stock Option | 2026-02-11 | A | A | 1,944 | $0.00 | 1,944 | D | $380.92 · — to 2033-02-11 | 1,944 Common Stock | (F3) Award granted under the 2023 Omnibus Incentive Plan. (F4) The option vests in two equal installments, the first half two years after the grant date and the final half three years after the grant date. |
| 7 | Derivative | Restricted Stock Unit | 2026-02-11 | A | A | 2,452 | $0.00 | 4,098.83 | D | — · — to — | 2,452 Common Stock | (F3) Award granted under the 2023 Omnibus Incentive Plan. (F6) Includes dividend equivalent units accrued with respect to the underlying RSUs. (F5) These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date. |